康泰医学: 康泰医学系统（秦皇岛）股份有限公司简式权益变动报告书

Core Viewpoint - The report outlines a significant reduction in shareholding by Hu Kun in Kangtai Medical Systems (Qinhuangdao) Co., Ltd., with a decrease of 7,377,869 shares, representing a 1.84% reduction in total shareholding [1][4]. Summary by Sections Section 1: Basic Information - The report is prepared in accordance with relevant Chinese laws and regulations, including the Securities Law and the Management Measures for the Acquisition of Listed Companies [1][2]. Section 2: Information Disclosure Obligation Person - The information disclosure obligation person is identified as Hu Kun, a male national of China, residing in Qinhuangdao, Hebei Province [3][4]. Section 3: Purpose of Equity Change - The equity change is primarily due to Hu Kun's personal funding needs, leading to a reduction in shareholding [4][5]. - There are no specific plans for increasing or decreasing shareholding in the next 12 months, although future changes may occur based on personal circumstances [4][5]. Section 4: Method of Equity Change - The reduction in shareholding was executed through centralized bidding and block trading methods [4][6]. - The total shares reduced were 7,377,869, which is 1.84% of the company's total share capital [4][6]. Section 5: Impact on the Company - The equity change will not alter the controlling shareholder or actual controller of the company, nor will it harm the interests of the company or other shareholders [4][5]. Section 6: Other Major Matters - There are no other significant matters related to this equity change that require disclosure [5][6].